Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000581979 | SCV000687479 | likely benign | Hereditary cancer-predisposing syndrome | 2017-03-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001053060 | SCV001217302 | likely benign | Ataxia-telangiectasia syndrome | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000581979 | SCV002614972 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-06-26 | criteria provided, single submitter | clinical testing | The c.3403-8_3403-4delTTTTT intronic variant is located upstream from coding exon 23 in the ATM gene. This variant results from a deletion of 5 nucleotides at positions c.3403-8 to c.3403-4. These nucleotide positions are generally well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing; however, direct evidence is insufficient at this time (Ambry internal data). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |